key takeaways in mpns
Published 2 years ago • 990 plays • Length 26:22Download video MP4
Download video MP3
Similar videos
-
13:31
key highlights in mpns: novel agents, combinations, and the potential role of immunotherapy
-
1:08
key takeaways in hemonc at asco 2022
-
2:43
the management of advanced phase mpns
-
1:51
checkpoint inhibition in the treatment of mpns
-
3:06
the role of artificial intelligence for precision medicine in multiple myeloma
-
1:49
advances in the science and treatment of mpns
-
1:45
new research areas in the treatment of aml
-
2:21
key takeaways from the texas mpn workshop 2020
-
1:52
the importance of symptom management in mpns
-
2:12
key emerging trials in cml and the importance of improving treatment-free remission rates
-
1:05
key takeaways in leukemia at asco 2022
-
16:35
key highlights in mpns at ash 2023: novel agents & combinations, ongoing clinical trials, and more
-
2:20
risk factors for progression in mpns
-
1:05
targeting the bclxl pathway in mpns
-
2:07
the clearance of driver mutations following allosct impacts myelofibrosis disease outcomes
-
1:00
insights into the future of the cll treatment landscape
-
8:40
investigating pp2a-based therapeutic strategies for kmt2a-rearranged acute leukemia
-
1:52
progress in mpns
-
2:05
new therapies for mpns
-
0:45
key trials in cll and designing a concept for treatment
-
2:56
novel drugs for myeloma thromboprophylaxis